Philip J. Rosenfeld
#131,986
Most Influential Person Now
Philip J. Rosenfeld's AcademicInfluence.com Rankings
Philip J. Rosenfeldphilosophy Degrees
Philosophy
#6448
World Rank
#9484
Historical Rank
Ontology
#59
World Rank
#69
Historical Rank
Logic
#3612
World Rank
#4801
Historical Rank
Download Badge
Philosophy
Why Is Philip J. Rosenfeld Influential?
(Suggest an Edit or Addition)Philip J. Rosenfeld's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Ranibizumab for neovascular age-related macular degeneration. (2006) (2402)
- Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase 1/2 studies (2015) (1038)
- Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. (2013) (976)
- An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration. (2007) (963)
- Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration. (2005) (942)
- A variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO Study. (2009) (875)
- Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration twelve-week results of an uncontrolled open-label clinical study. (2005) (679)
- Optical coherence tomography angiography: A comprehensive review of current methods and clinical applications (2017) (568)
- The International Intravitreal Bevacizumab Safety Survey: using the internet to assess drug safety worldwide (2006) (567)
- Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1-year results of a randomized clinical trial--VIP report no. 1. (2001) (500)
- Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1-year results of a randomized clinical trial--VIP report no. 1. (2001) (500)
- SHORT-TERM SAFETY AND EFFICACY OF INTRAVITREAL BEVACIZUMAB (AVASTIN) FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION (2006) (492)
- Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for macular edema from central retinal vein occlusion. (2005) (492)
- A Null mutation in the rhodopsin gene causes rod photoreceptor dysfunction and autosomal recessive retinitis pigmentosa (1992) (416)
- Ranibizumab for treatment of neovascular age-related macular degeneration: a phase I/II multicenter, controlled, multidose study. (2006) (402)
- Consensus Definition for Atrophy Associated with Age-Related Macular Degeneration on OCT: Classification of Atrophy Report 3. (2017) (394)
- NOVEL METHOD FOR ANALYZING SNELLEN VISUAL ACUITY MEASUREMENTS (2010) (370)
- Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial--VIP report no. 3. (2003) (370)
- Predicted biological activity of intravitreal VEGF Trap (2008) (357)
- Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3. (2014) (336)
- Vision Loss after Intravitreal Injection of Autologous "Stem Cells" for AMD. (2017) (331)
- Ranibizumab: Phase III clinical trial results. (2006) (297)
- Consensus Nomenclature for Reporting Neovascular Age-Related Macular Degeneration Data: Consensus on Neovascular Age-Related Macular Degeneration Nomenclature Study Group. (2019) (287)
- Effect of lesion size, visual acuity, and lesion composition on visual acuity change with and without verteporfin therapy for choroidal neovascularization secondary to age-related macular degeneration: TAP and VIP report no. 1. (2003) (255)
- Systemic complement inhibition with eculizumab for geographic atrophy in age-related macular degeneration: the COMPLETE study. (2014) (254)
- Characteristics of patients losing vision after 2 years of monthly dosing in the phase III ranibizumab clinical trials. (2011) (243)
- Maximum tolerated dose of a humanized anti-vascular endothelial growth factor antibody fragment for treating neovascular age-related macular degeneration. (2005) (239)
- Ultrahigh-Speed, Swept-Source Optical Coherence Tomography Angiography in Nonexudative Age-Related Macular Degeneration with Geographic Atrophy. (2015) (235)
- PHARMACOKINETIC RATIONALE FOR DOSING EVERY 2 WEEKS VERSUS 4 WEEKS WITH INTRAVITREAL RANIBIZUMAB, BEVACIZUMAB, AND AFLIBERCEPT (VASCULAR ENDOTHELIAL GROWTH FACTOR TRAP-EYE) (2011) (230)
- Ultrahigh-speed swept-source OCT angiography in exudative AMD. (2014) (218)
- Age-related maculopathy: a genomewide scan with continued evidence of susceptibility loci within the 1q31, 10q26, and 17q25 regions. (2004) (214)
- Optical Coherence Tomography Angiography of Asymptomatic Neovascularization in Intermediate Age-Related Macular Degeneration. (2016) (213)
- Progression of geographic atrophy in age-related macular degeneration imaged with spectral domain optical coherence tomography. (2011) (211)
- Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration: twenty-four-week results of an uncontrolled open-label clinical study. (2006) (206)
- A Novel Strategy for Quantifying Choriocapillaris Flow Voids Using Swept-Source OCT Angiography (2018) (199)
- Verteporfin therapy of subfoveal minimally classic choroidal neovascularization in age-related macular degeneration: 2-year results of a randomized clinical trial. (2005) (198)
- Tolerability and efficacy of multiple escalating doses of ranibizumab (Lucentis) for neovascular age-related macular degeneration. (2006) (198)
- Quantitative assessment of the retinal microvasculature using optical coherence tomography angiography (2016) (191)
- ZEISS Angioplex™ Spectral Domain Optical Coherence Tomography Angiography: Technical Aspects. (2016) (189)
- Swept-source OCT angiography of the retinal vasculature using intensity differentiation-based optical microangiography algorithms. (2014) (187)
- Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin: fluorescein angiographic guidelines for evaluation and treatment--TAP and VIP report No. 2. (2003) (186)
- Complement C3 Inhibitor Pegcetacoplan for Geographic Atrophy Secondary to Age-Related Macular Degeneration: A Randomized Phase 2 Trial. (2020) (186)
- Comparison Between Spectral-Domain and Swept-Source Optical Coherence Tomography Angiographic Imaging of Choroidal Neovascularization (2017) (167)
- Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: four-year results of an open-label extension of 2 randomized clinical trials: TAP Report No. 7. (2002) (166)
- Natural history of drusen morphology in age-related macular degeneration using spectral domain optical coherence tomography. (2011) (162)
- Spectral domain optical coherence tomography imaging of drusen in nonexudative age-related macular degeneration. (2011) (158)
- Age-related maculopathy: an expanded genome-wide scan with evidence of susceptibility loci within the 1q31 and 17q25 regions. (2001) (147)
- Imaging Protocols in Clinical Studies in Advanced Age-Related Macular Degeneration: Recommendations from Classification of Atrophy Consensus Meetings. (2017) (146)
- Natural History of Subclinical Neovascularization in Nonexudative Age-Related Macular Degeneration Using Swept-Source OCT Angiography. (2017) (145)
- PATHWAY-BASED THERAPIES FOR AGE-RELATED MACULAR DEGENERATION: An Integrated Survey of Emerging Treatment Alternatives (2010) (144)
- Acute severe visual acuity decrease after photodynamic therapy with verteporfin: case reports from randomized clinical trials-TAP and VIP report no. 3. (2004) (139)
- Mutations in ABCR (ABCA4) in patients with Stargardt macular degeneration or cone-rod degeneration. (2001) (135)
- Aflibercept for age-related macular degeneration: a game-changer or quiet addition? (2012) (133)
- ENDOPHTHALMITIS AFTER INTRAVITREAL ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR ANTAGONISTS: A Six-Year Experience at a University Referral Center (2011) (131)
- Pharmacotherapy for neovascular age-related macular degeneration: an analysis of the 100% 2008 medicare fee-for-service part B claims file. (2011) (127)
- Antivascular endothelial growth factor therapy for neovascular age-related macular degeneration (2009) (126)
- Intravitreal avastin: the low cost alternative to lucentis? (2006) (122)
- Square root transformation of geographic atrophy area measurements to eliminate dependence of growth rates on baseline lesion measurements: a reanalysis of age-related eye disease study report no. 26. (2013) (115)
- Conbercept for Treatment of Neovascular Age-related Macular Degeneration: Results of the Randomized Phase 3 PHOENIX Study. (2019) (112)
- Swept-source OCT angiography of macular telangiectasia type 2. (2014) (109)
- Lutein/zeaxanthin for the treatment of age-related cataract: AREDS2 randomized trial report no. 4. (2013) (104)
- SWEPT-SOURCE OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY REVEALS CHORIOCAPILLARIS ALTERATIONS IN EYES WITH NASCENT GEOGRAPHIC ATROPHY AND DRUSEN-ASSOCIATED GEOGRAPHIC ATROPHY (2016) (104)
- Bestrophin gene mutations in patients with Best vitelliform macular dystrophy. (1999) (103)
- Incomplete Retinal Pigment Epithelial and Outer Retinal Atrophy in Age-Related Macular Degeneration: Classification of Atrophy Meeting Report 4. (2019) (103)
- Progression of Geographic Atrophy in Age-related Macular Degeneration: AREDS2 Report Number 16. (2018) (100)
- Progression of Geographic Atrophy in Age-related Macular Degeneration: AREDS2 Report Number 16. (2018) (100)
- Drusen Volume as a Predictor of Disease Progression in Patients With Late Age-Related Macular Degeneration in the Fellow Eye. (2016) (100)
- TOWARD QUANTITATIVE OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY: Visualizing Blood Flow Speeds in Ocular Pathology Using Variable Interscan Time Analysis (2016) (99)
- Anti-vascular endothelial growth factor therapy for neovascular ocular diseases other than age-related macular degeneration (2009) (98)
- Effect of Ciliary Neurotrophic Factor on Retinal Neurodegeneration in Patients with Macular Telangiectasia Type 2: A Randomized Clinical Trial. (2019) (95)
- Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: three-year results of an open-label extension of 2 randomized clinical trials--TAP Report no. 5. (2002) (93)
- Projection artifact removal improves visualization and quantitation of macular neovascularization imaged by optical coherence tomography angiography. (2017) (93)
- Optical Coherence Tomography Angiography of Dry Age-Related Macular Degeneration. (2016) (92)
- Anti-Vascular Endothelial Growth Factor Agents in the Treatment of Retinal Disease: From Bench to Bedside. (2016) (91)
- Comparison of Aflibercept, Bevacizumab, and Ranibizumab for Treatment of Diabetic Macular Edema: Extrapolation of Data to Clinical Practice. (2016) (90)
- Automated Quantitation of Choroidal Neovascularization: A Comparison Study Between Spectral-Domain and Swept-Source OCT Angiograms (2017) (89)
- Emixustat Hydrochloride for Geographic Atrophy Secondary to Age-Related Macular Degeneration: A Randomized Clinical Trial. (2018) (87)
- SWEPT SOURCE OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY OF NEOVASCULAR MACULAR TELANGIECTASIA TYPE 2 (2015) (86)
- ONE-YEAR SAFETY AND EFFICACY OF INTRAVITREAL TRIAMCINOLONE ACETONIDE FOR THE MANAGEMENT OF MACULAR EDEMA SECONDARY TO CENTRAL RETINAL VEIN OCCLUSION (2006) (84)
- Predicting the progression of geographic atrophy in age-related macular degeneration with SD-OCT en face imaging of the outer retina. (2013) (84)
- Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: meta-analysis of 2-year safety results in three randomized clinical trials: Treatment Of Age-Related Macular Degeneration With Photodynamic Therapy and Verteporfin In Photodynamic Therapy Study Report (2004) (84)
- Anatomic Clinical Trial Endpoints for Nonexudative Age-Related Macular Degeneration. (2016) (84)
- Outcomes of treatment of neovascular glaucoma with intravitreal bevacizumab (2008) (83)
- Age-dependent Changes in the Macular Choriocapillaris of Normal Eyes Imaged With Swept-Source Optical Coherence Tomography Angiography. (2019) (79)
- Promising new treatments for neovascular age-related macular degeneration (2006) (78)
- Management of submacular hemorrhage secondary to neovascular age-related macular degeneration with anti-vascular endothelial growth factor monotherapy. (2012) (78)
- Spectral domain optical coherence tomographic imaging of geographic atrophy. (2008) (76)
- Correlations between Choriocapillaris Flow Deficits around Geographic Atrophy and Enlargement Rates Based on Swept-Source OCT Imaging. (2019) (76)
- Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin in the ocular histoplasmosis syndrome: one-year results of an uncontrolled, prospective case series. (2002) (74)
- ABCR Gene and Age-Related Macular Degeneration (1998) (70)
- Change in drusen volume as a novel clinical trial endpoint for the study of complement inhibition in age-related macular degeneration. (2013) (69)
- BEVACIZUMAB (AVASTIN) THERAPY FOR IDIOPATHIC MACULAR TELANGIECTASIA TYPE II (2009) (69)
- Bevacizumab versus ranibizumab for AMD. (2011) (68)
- Registration of OCT fundus images with color fundus photographs based on blood vessel ridges (2010) (67)
- Comparison of geographic atrophy measurements from the OCT fundus image and the sub-RPE slab image. (2013) (61)
- Longitudinal Wide-Field Swept-Source OCT Angiography of Neovascularization in Proliferative Diabetic Retinopathy after Panretinal Photocoagulation. (2019) (61)
- Macular spectral-domain optical coherence tomography in patients with X linked retinoschisis (2008) (61)
- Optical Coherence Tomography and the Development of Antiangiogenic Therapies in Neovascular Age-Related Macular Degeneration (2016) (60)
- Age-Related Changes in Choroidal Thickness and the Volume of Vessels and Stroma Using Swept-Source OCT and Fully Automated Algorithms. (2020) (58)
- Pseudocystic foveal cavitation in tamoxifen retinopathy. (2014) (58)
- Accurate estimation of choriocapillaris flow deficits beyond normal intercapillary spacing with swept source OCT angiography. (2018) (58)
- Current Infectious Endophthalmitis Rates After Intravitreal Injections of Anti-Vascular Endothelial Growth Factor Agents and Outcomes of Treatment. (2015) (58)
- Age-related macular degeneration: clinical findings, histopathology and imaging techniques. (2014) (58)
- Avastin doesn't blind people, people blind people. (2012) (56)
- Long-term outcomes of neovascular glaucoma treated with and without intravitreal bevacizumab (2016) (55)
- Choroidal Thickness and Choroidal Vessel Density in Nonexudative Age-Related Macular Degeneration Using Swept-Source Optical Coherence Tomography Imaging (2016) (55)
- SAFETY AND EFFICACY OF INTRAVITREAL BEVACIZUMAB (AVASTIN) FOR THE MANAGEMENT OF BRANCH AND HEMIRETINAL VEIN OCCLUSION (2009) (55)
- Photodynamic therapy with verteporfin in ocular histoplasmosis: uncontrolled, open-label 2-year study. (2004) (54)
- Quantification of choriocapillaris with Phansalkar's local thresholding: pitfalls to avoid. (2020) (52)
- Quantitative imaging of retinal pigment epithelial detachments using spectral-domain optical coherence tomography. (2012) (51)
- COMPARISON OF INTRAVITREAL BEVACIZUMAB FOLLOWED BY RANIBIZUMAB FOR THE TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION (2009) (50)
- Quantification of Choriocapillaris with Optical Coherence Tomography Angiography: A Comparison Study (2019) (50)
- Intravitreal triamcinolone acetonide for idiopathic cystoid macular edema. (2003) (48)
- Limitations of the American Academy of Neurology and American Clinical Neurophysiology Society paper on QEEG. (1999) (48)
- Appearance of Polypoidal Lesions in Patients With Polypoidal Choroidal Vasculopathy Using Swept-Source Optical Coherence Tomographic Angiography. (2019) (47)
- Distribution of Diabetic Neovascularization on Ultra-Widefield Fluorescein Angiography and on Simulated Widefield OCT Angiography. (2019) (46)
- Current Clinical Trials in Dry AMD and the Definition of Appropriate Clinical Outcome Measures (2011) (46)
- Outcomes of vitreoretinal surgery in patients with X-linked retinoschisis. (1998) (46)
- Guidelines for imaging the choriocapillaris using OCT angiography. (2020) (45)
- Optical coherence tomography measurements of choroidal thickness in healthy eyes: correlation with age and axial length. (2015) (45)
- Towards Treatment of Stargardt Disease: Workshop Organized and Sponsored by the Foundation Fighting Blindness (2017) (45)
- Recent advances in the gene map of inherited eye disorders: primary hereditary diseases of the retina, choroid, and vitreous. (1994) (44)
- Bilateral Retinal Detachments After Intravitreal Injection of Adipose-Derived 'Stem Cells' in a Patient With Exudative Macular Degeneration. (2017) (44)
- Association Between Subfoveal Choroidal Thickness, Reticular Pseudodrusen, and Geographic Atrophy in Age-Related Macular Degeneration. (2015) (43)
- Attenuation correction assisted automatic segmentation for assessing choroidal thickness and vasculature with swept-source OCT. (2018) (42)
- Suspended Scattering Particles in Motion: A Novel Feature of OCT Angiography in Exudative Maculopathies. (2017) (39)
- Comparison of Geographic Atrophy Growth Rates Using Different Imaging Modalities in the COMPLETE Study. (2015) (39)
- Comparison of drusen area detected by spectral domain optical coherence tomography and color fundus imaging. (2013) (37)
- SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY CHARACTERISTICS OF CUTICULAR DRUSEN (2009) (37)
- Spectral domain optical coherence tomography imaging of dry age-related macular degeneration. (2010) (36)
- Visual acuity after cataract surgery in patients with age-related macular degeneration: age-related eye disease study 2 report number 5. (2014) (36)
- Response to aflibercept after frequent re-treatment with bevacizumab or ranibizumab in eyes with neovascular AMD. (2014) (36)
- Treatment of Dry Age-Related Macular Degeneration (2014) (36)
- LONG-TERM SAFETY AND EFFICACY OF INTRAVITREAL BEVACIZUMAB (AVASTIN) FOR THE MANAGEMENT OF CENTRAL RETINAL VEIN OCCLUSION (2008) (35)
- Automatic montage of SD-OCT data sets (2011) (35)
- Cataract surgery in ranibizumab-treated patients with neovascular age-related macular degeneration from the phase 3 ANCHOR and MARINA trials. (2011) (35)
- NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: ROUNDTABLE (2005) (35)
- Wide-field optical coherence tomography angiography enabled by two repeated measurements of B-scans. (2016) (34)
- Predictive Value of the OCT Double-Layer Sign for Identifying Subclinical Neovascularization in Age-Related Macular Degeneration. (2019) (33)
- Optical Coherence Tomography Angiography of Macular Telangiectasia Type 2. (2016) (33)
- Two-Year Risk of Exudation in Eyes with Non-Exudative AMD and Subclinical Neovascularization Detected with Swept Source OCT Angiography. (2019) (32)
- A Randomized Phase 2 Study of an Anti-Amyloid β Monoclonal Antibody in Geographic Atrophy Secondary to Age-Related Macular Degeneration. (2018) (32)
- Oral Tyrosine Kinase Inhibitor for Neovascular Age-Related Macular Degeneration: A Phase 1 Dose-Escalation Study (2017) (32)
- Prophylaxis for endophthalmitis following intravitreal injection: antisepsis and antibiotics. (2011) (32)
- QUANTITATIVE CHANGES IN RETINAL PIGMENT EPITHELIAL DETACHMENTS AS A PREDICTOR FOR RETREATMENT WITH ANTI-VEGF THERAPY (2013) (32)
- Imaging serpiginous choroidopathy with spectral domain optical coherence tomography. (2008) (31)
- Imaging Features Associated with Progression to Geographic Atrophy in Age-Related Macular Degeneration: CAM Report 5. (2020) (31)
- Estimating Public and Patient Savings From Basic Research-A Study of Optical Coherence Tomography in Managing Antiangiogenic Therapy. (2018) (31)
- Natural History of Drusenoid Pigment Epithelial Detachment Associated with Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report No. 17. (2019) (30)
- OCT minimum intensity as a predictor of geographic atrophy enlargement. (2014) (29)
- Age related macular degeneration (2010) (27)
- Structural OCT Signs Suggestive of Subclinical Nonexudative Macular Neovascularization in Eyes with Large Drusen. (2019) (27)
- Artifactual Flow Signals Within Drusen Detected by OCT Angiography. (2016) (27)
- Medical consequences of stopping anticoagulant therapy before intraocular surgery or intravitreal injections. (2007) (27)
- Change in drusen area over time compared using spectral-domain optical coherence tomography and color fundus imaging. (2014) (26)
- Comparing total macular volume changes measured by Optical Coherence Tomography with retinal lesion volume estimated by active contours. (2004) (26)
- En Face Optical Coherence Tomography Imaging for the Detection of Nascent Geographic Atrophy. (2017) (26)
- Low incidence of retinitis pigmentosa among heterozygous carriers of a specific rhodopsin splice site mutation. (1995) (25)
- Swept-Source OCT Angiography Shows Sparing of the Choriocapillaris in Multiple Evanescent White Dot Syndrome. (2017) (25)
- Characterizing New-Onset Exudation in the Randomized Phase 2 FILLY Trial of Complement Inhibitor Pegcetacoplan for Geographic Atrophy. (2021) (25)
- Counterfeit Avastin in India: Punish the Criminals, Not the Patients. (2016) (25)
- Widefield En Face Optical Coherence Tomography Imaging of Subretinal Drusenoid Deposits. (2015) (23)
- Nonexudative Macular Neovascularization - A Systematic Review of Prevalence, Natural History, and Recent Insights from OCT Angiography. (2020) (23)
- Estimating Medicare and Patient Savings From the Use of Bevacizumab for the Treatment of Exudative Age-related Macular Degeneration. (2018) (22)
- Intravitreal Avastin for choroidal neovascularisation in pathological myopia: the controversy continues (2007) (22)
- Calibration of fundus images using spectral domain optical coherence tomography. (2008) (22)
- Spectral-domain optical coherence tomography measurements of choroidal thickness and outer retinal disruption in macular telangiectasia type 2. (2015) (21)
- Comparison of Neovascular Lesion Area Measurements From Different Swept-Source OCT Angiographic Scan Patterns in Age-Related Macular Degeneration (2017) (20)
- Endophthalmitis Associated With Intravitreal Injections of Anti-VEGF Agents at a Tertiary Referral Center: In-House and Referred Cases. (2018) (20)
- Purtscher-like retinopathy associated with pancreatic adenocarcinoma. (1999) (20)
- Prediction of age-related macular degeneration disease using a sequential deep learning approach on longitudinal SD-OCT imaging biomarkers (2020) (20)
- Correlations Between Choriocapillaris and Choroidal Measurements and the Growth of Geographic Atrophy using Swept Source OCT Imaging. (2020) (20)
- Retinal Non-Perfusion in Proliferative Diabetic Retinopathy Before and After Panretinal Photocoagulation Assessed by Wide Field OCT Angiography. (2020) (19)
- Analyzing Relative Blood Flow Speeds in Choroidal Neovascularization Using Variable Interscan Time Analysis OCT Angiography. (2017) (19)
- Comparison between Widefield En Face Swept-Source OCT and Conventional Multimodal Imaging for the Detection of Reticular Pseudodrusen. (2017) (19)
- Visual Acuity Outcomes Following a Variable–Dosing Regimen for Ranibizumab (LucentisTM) in Neovascular AMD: The PrONTO Study (2006) (18)
- TOWARD QUANTITATIVE OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY: Visualizing Blood Flow Speeds in Ocular Pathology Using Variable Interscan Time Analysis. (2016) (18)
- Quantification of choriocapillaris with OCTA: a comparison study. (2019) (18)
- [Treatment of neovascular age-related macular degeneration with Ranibizumab/Lucentis]. (2005) (18)
- SPECTRAL-DOMAIN OPTICAL COHERENCE TOMOGRAPHY IMAGING OF DRUSENOID PIGMENT EPITHELIAL DETACHMENTS (2013) (18)
- Impact of Baseline Characteristics on Geographic Atrophy Progression in the FILLY Trial Evaluating the Complement C3 Inhibitor Pegcetacoplan. (2021) (17)
- Automated detection of the foveal center improves SD-OCT measurements of central retinal thickness. (2012) (17)
- RETINAL TOXICITY OF COMMERCIALLY AVAILABLE INTRAVITREAL KETOROLAC IN ALBINO RABBITS (2009) (17)
- Choroidal Thickness in Eyes With Central Geographic Atrophy Secondary to Stargardt Disease and Age-Related Macular Degeneration. (2015) (16)
- Quantifying choriocapillaris flow deficits using global and localized thresholding methods: a correlation study. (2018) (16)
- Interpretation of Subretinal Fluid Using OCT in Intermediate Age-Related Macular Degeneration. (2018) (16)
- Lessons from Recent Phase III Trial Failures: Don't Design Phase III Trials Based on Retrospective Subgroup Analyses from Phase II Trials. (2018) (16)
- [Early effects of systemic and intravitreal bevacizumab (avastin) therapy for neovascular age-related macular degeneration]. (2006) (16)
- Endophthalmitis is not a "never event". (2012) (16)
- Correlations between Different Choriocapillaris Flow Deficit Parameters in Normal Eyes using Swept Source OCT Angiography. (2020) (15)
- Swept-source OCT Angiography of the Retinal Vasculature using Intensity Differentiation Based OMAG Algorithms (2015) (14)
- Geometric Deformable Model Driven by CoCRFs: Application to Optical Coherence Tomography (2008) (14)
- Verteporfin photodynamic therapy of choroidal neovascularization secondary to ocular toxoplasmosis. (2006) (14)
- En Face Imaging of Geographic Atrophy Using Different Swept-Source OCT Scan Patterns. (2019) (14)
- Multimodal Imaging of Punctate Outer Retinal Toxoplasmosis. (2019) (13)
- COMPARISON OF 2.5 mg/kg AND 5 mg/kg SYSTEMIC BEVACIZUMAB IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Twenty-Four Week Results of an Uncontrolled, Prospective Cohort Study (2008) (13)
- Is This a 737 Max Moment for Brolucizumab? (2020) (13)
- Longitudinal Angiographic Evidence that Intraretinal Microvascular Abnormalities Can Evolve into Neovascularization. (2020) (12)
- Scleral buckle infection with ciprofloxacin-resistant Pseudomonas aeruginosa. (1998) (12)
- Anti–Vascular Endothelial Growth Factor Therapy in Pregnancy: What We Know, What We Don't Know, and What We Don't Know We Don't Know (2016) (12)
- Persistent indocyanine green angiographic findings in multiple evanescent white dot syndrome. (2001) (12)
- A Comparison Study of Polypoidal Choroidal Vasculopathy Imaged with Indocyanine Green Angiography and Swept Source OCT Angiography. (2020) (12)
- Why choroid vessels appear dark in clinical OCT images (2018) (11)
- Widefield Swept-Source Optical Coherence Tomography Angiography of Proliferative Diabetic Retinopathy. (2019) (11)
- Validation of a Novel Automated Algorithm to Measure Drusen Volume and Area Using Swept Source Optical Coherence Tomography Angiography (2021) (11)
- RhuFab V2 (Anti-VEGF Antibody Fragment) in Neovascular AMD: Safety, Tolerability, and Efficacy of Multiple, Escalating Dose Intravitreal Injections (2003) (11)
- Antiangiogenic Therapy in Neovascular Age-related Macular Degeneration (2007) (11)
- APEX: a phase II randomised clinical trial evaluating the safety and preliminary efficacy of oral X-82 to treat exudative age-related macular degeneration (2020) (11)
- Optical coherence tomography findings in hydroxychloroquine and chloroquine-associated maculopathy. (2007) (11)
- Age-Dependent Changes in the Macular Choriocapillaris of Normal Eyes Imaged with Swept-Source OCT Angiography. (2019) (10)
- Preventing the Growth of Geographic Atrophy: An Important Therapeutic Target in Age-Related Macular Degeneration. (2018) (10)
- Are Dilated Fundus Examinations Needed for OCT-Guided Retreatment of Exudative Age-Related Macular Degeneration? (2019) (10)
- Spectral Domain Optical Coherence Tomography Imaging of Drusen in Non-Exudative Age-Related Macular Degeneration (2011) (10)
- Verteporfin therapy of subfoveal occult choroidal neovascularization in AMD using delayed light application: one-year results of the VALIO Study. (2007) (10)
- Bevacizumab!versus!Ranibizumab!—!The!Verdict (2011) (10)
- When is off-label drug use in the patient's best interest? (2009) (10)
- Eliminating Visual Acuity and Dilated Fundus Examinations Improves Cost Efficiency of Performing Optical Coherence Tomogrpahy–Guided Intravitreal Injections (2020) (10)
- Verteporfin In Minimally Classic CNV due to AMD (VIM) – Two–Year Results from a Phase II Controlled Clinical Trial (2004) (10)
- Optical Coherence Tomography Angiography of Chorioretinal Diseases. (2016) (10)
- Topical OT-551 for Treating Geographic Atrophy: Phase II Results (2010) (10)
- Warning: Do Not Treat Intermediate AMD with Laser Therapy. (2019) (10)
- Lessons Learned From Avastin and OCT–The Great, the Good, the Bad, and the Ugly: The LXXV Edward Jackson Memorial Lecture (2019) (10)
- Association Between Growth of Geographic Atrophy and the Complement Factor I Locus. (2015) (10)
- Increasing volume of a retinal pigmented epithelial detachment as a predictor of submacular hemorrhage during anti-VEGF therapy. (2013) (9)
- Validation of a Compensation Strategy used to Detect Choriocapillaris Flow Deficits Under Drusen with Swept Source OCT Angiography. (2020) (9)
- Swept-Source OCT Angiographic Characteristics of Treatment-Naïve Nonexudative Macular Neovascularization in AMD Prior to Exudation (2021) (9)
- Verteporfin in Photodynamic Therapy: report no. 5. (2004) (9)
- Deliberations of an International Panel of Experts on OCTA Nomenclature of nAMD. (2020) (8)
- Persistent Hyper-Transmission Defects Detected on En Face Swept Source OCT Images Predict the Formation of Geographic Atrophy in AMD (2021) (8)
- An Update on the Hemodynamic Model of Age-Related Macular Degeneration. (2021) (8)
- Dose-Response Relationship Between Recurrent Intravitreal Injections and Retinal Nerve Fiber Layer Thinning in Exudative AMD. (2020) (8)
- Comparison Between Graders in Detection of Diabetic Neovascularization with Swept Source OCT Angiography and Fluorescein Angiography. (2020) (7)
- Epiretinal macular edema associated with thick epiretinal membranes. (2013) (7)
- Intravitreal conbercept for diabetic macular oedema: 2-year results from a randomised controlled trial and open-label extension study (2021) (7)
- Persistent Hyper-Transmission Defects on En Face OCT Imaging as a Stand-Alone Precursor for the Future Formation of Geographic Atrophy. (2021) (7)
- Wide field swept source OCT angiography in acute syphilitic placoid chorioretinitis (2020) (7)
- Verteporfin with Altered (Delayed) Light In Occult (VALIO) – 12–Month Results of a Phase II Controlled Clinical Trial (2004) (7)
- Swept-Source Optical Coherence Tomography Angiography of an Amalric Choroidal Infarction in a Rare Presentation of Giant Cell Arteritis With Bilateral Corneal Edema. (2018) (7)
- A Novel Method to Detect and Monitor Retinal Vasculitis Using Swept Source OCT Angiography. (2021) (6)
- Predicting the Onset of Exudation in Treatment-Naïve Eyes with Nonexudative Age-Related Macular Degeneration. (2022) (6)
- Long–Term Experience With LucentisTM (Ranibizumab) in Patients With Neovascular Age–Related Macular Degeneration (AMD) (2005) (6)
- Incomplete Retinal Pigment Epithelial and Outer Retinal Atrophy (iRORA) in Age-related Macular Degeneration: CAM Report 4 (2020) (6)
- Durability of Systemic Bevacizumab (Avastin®) Therapy for Neovascular Age–Related Macular Degeneration (2005) (6)
- A Phase II Placebo-Controlled, Double-Masked, Randomized Trial - Verteporfin in Minimally Classic CNV Due to AMD (VIM) (2003) (6)
- Crescent-Shaped Retinal Defects Associated With Membrane Peeling With a Diamond-Dusted Membrane Scraper. (2016) (6)
- Pharmacotherapy of Age-Related Macular Degeneration (2012) (6)
- Verteporfin therapy for CNV secondary to OHS. (2006) (6)
- Choroidal Changes in Eyes With Polypoidal Choroidal Vasculopathy After Anti-VEGF Therapy Imaged With Swept-Source OCT Angiography (2021) (6)
- Idiopathic macular telangiectasis type 2 and co-existent diabetic retinopathy (2017) (6)
- Presence or absence of choroidal hyper-transmission by SD-OCT imaging distinguishes inflammatory from neovascular lesions in myopic eyes (2020) (6)
- An OCT-Guided Variable-Dosing Regimen With Ranibizumab (Lucentis) in Neovascular AMD: Two Year Results of the PrONTO Study (2007) (5)
- Analysis of correlations between local geographic atrophy growth rates and local OCT angiography-measured choriocapillaris flow deficits. (2021) (5)
- Wide field swept source OCT angiography of multifocal retinal and choroidal occlusions from embolic triamcinolone acetonide (2020) (5)
- Local Geographic Atrophy Growth Rates Not Influenced by Close Proximity to Non-Exudative Type 1 Macular Neovascularization (2022) (5)
- Spectral-domain Optical Coherence Tomography Imaging of Age-related Macular Degeneration (2011) (5)
- Replacement of polyps with type 1 macular neovascularization in polypoidal choroidal vasculopathy imaged with swept source OCT angiography (2021) (5)
- Detection of Choriocapillaris Loss in Alport Syndrome With Swept-Source OCT Angiography. (2018) (5)
- Imaging of Epiretinal Membranes Using En Face Widefield Swept-Source Optical Coherence Tomography. (2019) (5)
- Automatic geographic atrophy segmentation using optical attenuation in OCT scans with deep learning. (2022) (5)
- A2E Distribution in RPE Granules in Human Eyes (2020) (5)
- Deliberations of an International Panel of Experts on OCT Angiography Nomenclature of Neovascular Age-Related Macular Degeneration (2021) (5)
- Anatomic Localization of Type 1 and Type 2 Macular Neovascularization Using Swept-Source OCT Angiography. (2018) (4)
- Photodynamic therapy of bullous central serous chorioretinopathy with subretinal exudate and a tear of the retinal pigment epithelium. (2009) (4)
- OCT Angiography (OCTA) of Diabetic Retinopathy (2015) (4)
- WIDE-FIELD SWEPT-SOURCE OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY OF DIABETIC TRACTIONAL RETINAL DETACHMENTS BEFORE AND AFTER SURGICAL REPAIR. (2021) (4)
- Strategies for Following Dry Age-Related Macular Degeneration (2012) (4)
- New approaches to the treatment of Age-Related Macular Degeneration (AMD). (2022) (4)
- The LXXV Edward Jackson Memorial Lecture: Lessons Learned from Avastin and OCT: The Great, The Good, The Bad, and The Ugly. (2019) (4)
- OCT Measurements of the Retinal Pigment Epithelium to Bruch's Membrane Thickness around Geographic Atrophy Correlate with Growth: Short title: Thickened RPE/BM complex predicts faster GA growth. (2021) (4)
- Toward quantitative OCT angiography: visualizing flow impairment using variable interscan time analysis (VISTA) (2016) (4)
- Swept-Source OCT Angiography Identifies Choroidal Neovascularization Arising From a Choroidal Nevus. (2018) (4)
- Diagnosing Persistent Hyper-Transmission Defects on En Face OCT Imaging of Age-Related Macular Degeneration. (2022) (4)
- Ridge-based retinal image registration algorithm involving OCT fundus images (2011) (4)
- Verteporfin With Altered (Delayed) Light in Occult CNV (VALIO) – Results of a Phase II Controlled Clinical Trial (2003) (4)
- Management of Neovascular AMD (2011) (4)
- New treatments for age-related macular degeneration (2007) (3)
- Macular Telangiectasia Type 1 Managed With Long-Term Aflibercept Therapy. (2016) (3)
- Developing a potential retinal OCT biomarker for local growth of geographic atrophy. (2020) (3)
- Advanced retinal imaging and applications for clinical practice: A consensus review. (2022) (3)
- Intravitreal Avastin Safety Survey: Results From the World Wide Web (2006) (3)
- Dr. Rosenfeld and colleagues reply [13] (2007) (3)
- Swept-Source OCT Angiography of Multiple Evanescent White Dot Syndrome With Inflammatory Retinal Pigment Epithelial Detachment. (2018) (3)
- Elimination of Post-Injection Topical Antibiotics After Intravitreal Injections (2009) (3)
- Anti-Vascular Endothelial Growth Factor Therapy for Choroidal Rupture-Associated Choroidal Neovascularization. (2020) (3)
- One year study of macular pigment enhancement by a lutein supplement (1997) (3)
- Using OCT Fundus Images to Evaluate the Performance of the Spectralis OCT Eye Tracking System (2011) (3)
- Multimodal Imaging and En Face OCT Detection of Calcified Drusen in Eyes with Age-Related Macular Degeneration (2022) (3)
- Genetics of age-related macular degeneration (2002) (3)
- Multimodal Imaging, OCT B-Scan Localization, and En Face OCT Detection of Macular Hyperpigmentation in Eyes with Intermediate Age-Related Macular Degeneration (2022) (3)
- Interocular asymmetry of choroidal thickness and vascularity index measurements in normal eyes assessed by swept-source optical coherence tomography (2021) (3)
- Preclinical and Phase 1 Drugs in Development for Dry AMD: An Overview (2009) (3)
- Baseline and Treatment Characteristics of Patients Losing Vision at Year 1 of the MARINA and ANCHOR Trials (2007) (3)
- Longitudinal Swept Source OCT Angiography of Juxtapapillary Retinal Capillary Hemangioblastoma. (2020) (3)
- Review of Emerging Treatments for Age-Related Macular Degeneration (2012) (3)
- Reply to Letter from Novartis on "Is this a 737 Max Moment for Brolucizumab?" (2020) (3)
- Growth Modeling for Quantitative, Spatially Resolved Geographic Atrophy Lesion Kinetics (2021) (3)
- Does the Outer Retinal Thickness Around Geographic Atrophy Represent Another Clinical Biomarker for Predicting Growth? (2022) (3)
- Type 2 choroidal neovascularisation in polypoidal choroidal vasculopathy: a retrospective case series (2018) (3)
- Swept-Source OCT Angiographic Imaging of a Central Retinal Vein Occlusion During Pregnancy. (2018) (3)
- OCT Angiography Helps Distinguish Between Proliferative Macular Telangiectasia Type 2 and Neovascular Age-Related Macular Degeneration. (2018) (3)
- Oral Tyrosine Kinase Inhibitors for Neovascular Age-Related Macular Degeneration. (2019) (3)
- My use of aflibercept in clinical practice (2012) (2)
- CHANGE IN CHORIOCAPILLARIS FLOW DEFICITS WITHIN TEARS OF THE RETINAL PIGMENT EPITHELIUM IMAGED WITH SWEPT-SOURCE OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY (2022) (2)
- Treatment Approaches for Dry AMD (2013) (2)
- Systemic Bevacizumab (Avastin®) Therapy for Neovascular Age–Related Macular Degeneration (SANA) Study: Visual Acuity Outcomes (2005) (2)
- Accurate visualization and quantification of choriocapillaris with swept source OCTA through averaging repeated volume scans (2018) (2)
- Lesion Characteristics in Ranibizumab (LUCENTIS®) Treated Patients With a Visual Acuity (VA) Gain or Loss in the MARINA and ANCHOR Trials for Wet Age-Related Macular Degeneration (AMD) (2008) (2)
- Standard vs. Reduced Dose Systemic Bevacizumab (Avastin®) for the Treatment of Neovascular Age–Related Macular Degeneration (2006) (2)
- SWEPT-SOURCE OPTICAL COHERENCE TOMOGRAPHY DETECTION OF BRUCH MEMBRANE AND CHORIOCAPILLARIS ABNORMALITIES IN SORSBY MACULAR DYSTROPHY (2022) (2)
- Comparison of Drusen Area Detected by Spectral Domain OCT and Color Fundus Photography (2010) (2)
- Imaging Drusen With Spectral Domain Optical Coherence Tomography (2008) (2)
- Identifying the boundaries of retinal pigment epithelial detachments using two spectral-domain optical coherence tomography instruments. (2013) (2)
- Optical Coherence Tomography Findings in a Variable–Dosing Regimen with Ranibizumab (LucentisTM): The PrONTO Study (2006) (2)
- Mitigating the effects of choroidal hyper- and hypo-transmission defects on choroidal vascularity index assessments using optical coherence tomography. (2021) (2)
- 3–D OCT Maps of Retinal Pathologies (2005) (2)
- An explanation for why choroidal blood vessels appear dark on clinical OCT images (2017) (2)
- Subfoveal Choroidal Thickness in Macular Telangiectasia Type 2 (2012) (2)
- Systemic Complement Inhibition With Eculizumab For The Treatment Of Geographic Atrophy In AMD Patients: The Complete Study (2012) (2)
- A deep learning model for automated segmentation of geographic atrophy imaged with swept-source optical coherence tomography images. (2022) (2)
- Widefield en face optical coherence tomography monitoring of the peri-venular fern-like pattern of paracentral acute middle maculopathy (2021) (2)
- [Therapeutic efficacy and safety of off-label use of Bevacizumab for the treatment of neovascular diseases of the eye]. (2008) (1)
- Depth-resolved visualization and automated quantification of hyperreflective foci on OCT scans using optical attenuation coefficients. (2022) (1)
- Ultra High-Resolution Optical Coherence Tomography for Non-contact Ocular Imaging of Small Animals (2008) (1)
- Intravitreal triamcinolone for the treatment of macular edema from central retinal vein occlusion (2004) (1)
- Laser-induced choroidal neovascularization detected on optical coherence tomography angiography in patients with diabetic retinopathy (2022) (1)
- The path to intravitreal bevacizumab (2009) (1)
- Characteristics of Patients Losing Vision at Year 1 of the PrONTO Study (2007) (1)
- Sequential Comparison of Avastin (Bevacizumab) Followed by Lucentis (Ranibizumab) in the Treatment of Neovascular Age Related Macular Degeneration (2007) (1)
- Automatic Algorithm for the Montage of Spectral Domain Optical Coherence Tomography (SD-OCT) Datasets (2011) (1)
- Re: Bilateral same-day intravitreal injections using a single vial and molecular bacterial screening for safety surveillance. (2013) (1)
- Abstract: OCT-OCTA Segmentation - A Novel Framework and an Application to Segment Bruch's Membrane in the Presence of Drusen (2017) (1)
- Impact of Reticular Pseudodrusen on Choriocapillaris Flow Deficits and Choroidal Structure on Optical Coherence Tomography Angiography (2022) (1)
- Progression of Polypoidal Lesions Associated with Exudative Recurrence in Polypoidal Choroidal Vasculopathy. (2022) (1)
- The Extent of Retinal Involvement of Canthaxanthin Crystalline Retinopathy Demonstrated by Multimodal Imaging. (2020) (1)
- Extrascleral Vitreous Prolapse Following Intravitreal Injection (2017) (1)
- LONGITUDINAL ANALYSIS OF DIABETIC CHOROIDOPATHY IN PROLIFERATIVE DIABETIC RETINOPATHY TREATED WITH PANRETINAL PHOTOCOAGULATION USING WIDEFIELD SWEPT-SOURCE OPTICAL COHERENCE TOMOGRAPHY (2021) (1)
- Comparing Accuracies of Length-Type Geographic Atrophy Growth Rate Metrics Using Atrophy-Front Growth Modeling (2022) (1)
- Correlation Between Choroidal Thickness At Baseline And Disease Progression In Eyes With Dry AMD: The COMPLETE Study (2012) (1)
- Identification of macular neovascularization in central serous chorioretinopathy using swept-source OCT angiography. (2023) (1)
- Widefield Swept-Source Optical Coherence Tomography Angiography of a "Polypoidal-Like" Retinal Arteriovenous Anastomosis in Proliferative Diabetic Retinopathy. (2021) (1)
- Automated volumetric choroidal neovascularization segmentation and quantification in swept-source OCT angiography using machine learning (2019) (1)
- Severe Vision Decrease within One Week following Photodynamic Therapy (2002) (1)
- Intravitreal Aflibercept in Eyes with Neovascular AMD Requiring Frequent Retreatment with Intravitreal Bevacizumab or Ranibizumab (2014) (1)
- Ultra high-resolution optical coherence tomography for ocular imaging of small animals (2009) (1)
- Measuring drusen over time: OCT vs. Fundus Photography (2013) (1)
- Detection of Nonexudative Macular Neovascularization on Structural OCT Images Using Vision Transformers (2022) (1)
- Current Endophthalmitis Incidence Rates After Intravitreal Anti-VEGF Injections and Outcomes of Treatment (2015) (1)
- Automated segmentation of geographic atrophy using U-Net on custom-generated SD-OCT en face images (2019) (1)
- Swept-Source OCT Imaging of the Argus II Epiretinal Prosthesis. (2017) (1)
- Impact of Cataract Surgery on Low Luminance Visual Acuity Deficit Measurements (2022) (1)
- Clinicopathologic Findings in Three Siblings With Geographic Atrophy (2023) (0)
- Importance of Sampling Density in the Analysis of Optical Coherence Tomography Angiography (2016) (0)
- Progression of Geographic Atrophy Imaged With Spectral Domain OCT (2009) (0)
- Spectral-Domain OCT Macular Montage for Imaging Geographic Atrophy (2009) (0)
- Intravitreal Avastin provides an opportunity to prevent visual acuity loss particularly in non-Western countries (2007) (0)
- Tractional Retinal Detachment In Severe Diabetic Retinopathy After The Injection Of Bevacizumab (avastin (2007) (0)
- Variable dosing strategies for neovascular AMD (2008) (0)
- Comparison Of SDOCT, Autofluorescence, And Fluorescein Angiography Imaging Of Geographic Atrophy (2012) (0)
- Influence Of Genetics On Baseline Characteristics And Disease Progression In Dry AMD (2012) (0)
- Automated Retinal Segmentation for Widefield OCT, with applications to OCT Angiography (2016) (0)
- ISOPT Clinical Hot Topic Panel Discussion on Medical Treatment of Retinal Diseases. (2019) (0)
- Contributing authors (1988) (0)
- Treatment of Geographic Atrophy: What’s on the Horizon? (2014) (0)
- Advances in High Throughput Small Animal Ocular Imaging With Spectral Domain OCT (2008) (0)
- Reply to Comment on: Conbercept for Treatment of Neovascular Age-Related Macular Degeneration: Results of the Randomized Phase 3 PHOENIX Study. (2020) (0)
- Multimodal imaging in the diagnosis and management of ophthalmia nodosa (2022) (0)
- Square Root Transformation Of Geographic Atrophy (GA) Measurements Removes Dependence Of 4 Year Growth On Initial GA Area : A Reanalysis Of Data From AREDS Report 26 (2011) (0)
- Diagnostic and therapeutic challenges. (2009) (0)
- Verteporfin Therapy of Predominantly Hemorrhagic Lesions in Patients with Neovascular AMD (2003) (0)
- A 38-year-old male complains of poor vision since childhood (2007) (0)
- Invited Speakers and Discussants (Commercial Relationship Disclosure) (2017) (0)
- SWEPT-SOURCE OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY REVEALS CHORIOCAPILLARIS ALTERATIONS IN EYES WITH NASCENT GEOGRAPHIC ATROPHY AND DRUSEN-ASSOCIATED GEOGRAPHIC ATROPHY. (2016) (0)
- Quantitative Changes of Retinal Pigment Epithelial Detachments Following Anti-VEGF Therapy using Spectral Domain Optical Coherence Tomography (2012) (0)
- Widefield En face Swept Source OCT Imaging of Geographic Atrophy, Retinal Pigment Epithelial Detachments, and Macular Hemorrhages (2015) (0)
- OCT Angiography (OCTA) in Healthy Human Subjects (2015) (0)
- Ultrahigh speed OCT angiography in age-related macular degeneration using swept source optical coherence tomography (2015) (0)
- Suspended Scattering Particles in Motion (SSPiM): A Feature of OCT Angiography in Diabetic Macular Edema (2017) (0)
- Polyps in Polypoidal Choroidal Vasculopathy Appear as Tangled Vascular Structures Using Swept-Source OCT Angiography (2019) (0)
- Automated segmentation and quantification of calcified drusen in 3D swept source OCT imaging. (2023) (0)
- Widefield Imaging of the retina using Swept Source OCT (2014) (0)
- Retinal Morphology Before and After the Treatment of Diabetic Retinopathy Evaluated With Spectral Domain Optical Coherence Tomography (2008) (0)
- Anti-VEGF Therapy - Managing Challenging Case Scenarios (2014) (0)
- Imaging Retinal Pigment Epithelial Detachments With Spectral Domain OCT (2009) (0)
- Widefield En face Swept Source OCT Imaging of Dry Age-Related Macular Degeneration Subretinal Drusenoid Deposits (2015) (0)
- Natural History Of Drusenoid Retinal Pigment Epithelial Detachments Using SDOCT Imaging (2012) (0)
- Prevalence of Quiescent Neovascularization in Intermediate and Late Non-Exudative Age-Related Macular Degeneration and the Incidence of Subsequent Exudation using Swept-Source Optical Coherence Tomography Angiography (2017) (0)
- Detecting Double Layer Signs with OCT volumes using a 3D Convolutional Neural Network (CNN) (2021) (0)
- Symmetry of Macular Fundus Features in Age-Related Macular Degeneration. (2023) (0)
- Reticular Pseudodrusen, Enlarging Geographic Atrophy, and Decreased Choroidal Thickness in Age-Related Macular Degeneration (2015) (0)
- Decreased Macular Choriocapillaris Perfusion in Eyes With Macular Reticular Pseudodrusen Imaged With Swept-Source OCT Angiography (2023) (0)
- Qualitative Analysis Of Intraretinal Pigment Using en-face SDOCT Imaging (2012) (0)
- Widefield En face OCT imaging of Subretinal Drusenoid Deposits (2015) (0)
- Early Retreatment of Choroidal Neovascularization (CNV) in Age-Related Macular Degeneration (AMD) Using Ocular Photodynamic Therapy (OPT) with Verteporfin (2002) (0)
- Comparison of choroidal thickness measurements in eyes with dry AMD using the Spectralis and Cirrus SDOCT instruments: The COMPLETE Study (2012) (0)
- A Phase 1 Safety Study of an Orally Available Tyrosine Kinase Inhibitor X-82 in Previously Treated Wet AMD Patients (2015) (0)
- OCT Angiography (OCTA) of Neovascularization in Macular Telangiectasia Type 2 (2016) (0)
- Comparison of Spectral Domain Optical Coherence Tomography Segmentation Algorithms in the Analysis of Pigment Epithelial Detachments (2011) (0)
- Comparison of Cirrus and Spectralis Spectral Domain OCT Measurements of Choroidal Thickness (2010) (0)
- Intravitreal Bevacizumab (Avastin®) for Macular Edema Secondary to Branch and Hemiretinal Vein Occlusions (2007) (0)
- Onset and Progression of Persistent Choroidal Hypertransmission Defects in Intermediate AMD: A Novel Clinical Trial Endpoint: Hypertransmission Defects as a Clinical Trial Endpoint. (2023) (0)
- Vision Outcomes Following Cataract Surgery in Ranibizumab (LUCENTIS®) Treated Patients With Wet Age-Related Macular Degeneration in MARINA and ANCHOR Trials (2009) (0)
- Author Response: Local Geographic Atrophy Growth Rates Not Influenced by Close Proximity to Non-Exudative Type 1 Macular Neovascularization (2022) (0)
- Retinal Pigment Epithelium Layer Segmentation Accuracy on Widefield High Resolution Optical Coherence Tomography Cubes (2017) (0)
- Effects of Enhancement of Blood Vessel Contrast in OCT Fundus Images on Registration Performance (2012) (0)
- Optical Coherence Tomography (OCT) Outcomes Following Systemic Bevacizumab (Avastin®) Therapy for Neovascular Age–Related Macular Degeneration (2005) (0)
- Variable Interscan Time Analysis (VISTA-) Optical Coherence Tomography Angiography (OCTA) of Blood Flow Speeds in Eyes with Diabetic Retinopathy (2017) (0)
- Indocyanine Green Angiographic Outcomes Following Systemic Bevacizumab (Avastin®) Therapy for Neovascular Age–Related Macular Degeneration (2005) (0)
- Acute-Onset Endophthalmitis Following Clear Corneal Cataract Surgery: A 12-Year Review (1996-2008) (2009) (0)
- Ultrahigh Speed Swept Source OCT Angiography in Non-Exudative Age-Related Macular Degeneration with Geographic Atrophy (2015) (0)
- Regression of Bilateral Peripapillary Choroidal Neovascularization Associated with Idiopathic Intracranial Hypertension after Systemic Acetazolamide Treatment (2022) (0)
- Reply: To PMID 22264942. (2013) (0)
- Minimum Intensity of OCT A-Scans at the Margins of Geographic Atrophy in AMD (2012) (0)
- Macular Spectral-Domain and Time-Domain Optical Coherence Tomography in Patients With X-Linked Retinoschisis (2008) (0)
- Cataract Surgery in Patients Receiving Intravitreal Bevacizumab or Ranibizumab for Neovascular AMD (2009) (0)
- Longitudinal quantification of choriocapillaris flow deficits in persistent placoid maculopathy: a case report (2023) (0)
- OCTA detects flow alterations in the choriocapillaris underlying drusen in non-exudative age-related macular degeneration without geographic atrophy (2016) (0)
- OCT Angiography (OCTA) of Macular Telangiectasia Type 2 (2015) (0)
- Severe retinal hemorrhages at various levels with a serous retinal detachment in a pediatric patient with aplastic anemia–A case report (2023) (0)
- Non–infectious Pseudohypopyon Following Intravitreal Triamcinolone Acetonide (IVTA) Injection (2005) (0)
- Imaging Exudative Age-Related Macular Degeneration Using Swept-Source Optical Coherence Tomography Angiography (2020) (0)
- Comparing Area Measurements of Choroidal Neovascularization Obtained using Different Swept Source OCT Angiographic Scan Patterns in Neovascular Age-Related Macular Degeneration (2017) (0)
- Reply (2020) (0)
- Swept Source OCT Angiography of Polypoidal Choroidal Vasculopathy using Boundary Layer Specific Segmentation (2017) (0)
- Correlations Between the Volumes of Fibrovascular Retinal Pigment Epithelial Detachments and the Areas of Type 1 Choroidal Neovascularization in Age-related Macular Degeneration using OCT imaging (2017) (0)
- Rates of Vision Loss in Patients with Geographic Atrophy in AREDS and AREDS 2 (2014) (0)
- Intravitreal Injection Trends in a Busy Academic Retina Practice (2010) (0)
- Widefield Choroidal Thickness Maps in Dry Age Related Macular Degeneration with and without Reticular Pseudodrusen (2015) (0)
- Three-Dimensional Modeling of Choroidal Neovascularization Using Spectral Domain Optical Coherence Tomography (2007) (0)
- Widefield Choroidal Thickness Distribution in Normal Eyes (2018) (0)
- Bevacizumab for Treatment of Neovascular Glaucoma (2010) (0)
- Correlation of Renal Function and C-reactive Protein, with Disease Severity and Progression In Eyes with Dry AMD (2012) (0)
- Automated Case-Adaptive Slab Configuration for Visualization of Choroidal Neovascularization in Swept-Source OCT Angiography (2017) (0)
- Choroidal Thickness In Eyes With Geographic Secondary To Stargardt Disease And Age-related Macular Degeneration (2012) (0)
- Endophthalmitis After Intravitreal Vascular Endothelial Growth Factor Antagonists: A Seven-year Experience At A University Referral Center.endophthalmitis After Intravitreal Vascular Endothelial Growth Factor Antagonists: A Seven-year Experience At A University Referral Center (2012) (0)
- Correlation of Vascular Impairment with Geographic Atrophy Progression Analyzed with Swept Source OCT Angiography and Variable Interscan Time Analysis (2017) (0)
- Verteporfin Therapy with Intravitreal Triamcinolone in Patients with Neovascular AMD (2004) (0)
- En-Face Imaging of Microcysts in Macular Teleangiectasia Type 2 Using Minimum- and Mean-Intensity Projections (2015) (0)
- Congress Abstracts (2017) (0)
- A Novel Algorithm for Quantitative Imaging of Retinal Pigment Epithelial Detachments using Spectral Domain Optical Coherence Tomography (2011) (0)
- Endophthalmitis Following Intravitreal Injections Is Very Rare in the Anti-VEGF Era (2008) (0)
- Flow Void Analysis: Multiscale Quantitation and Visualization of Choriocapillaris Alterations in Age-Related Macular Degeneration Using OCT Angiography (2017) (0)
- The Role of Optical Coherence Tomography in Anti-Vascular Endothelial Growth Factor Therapies (2009) (0)
- Comparison of 2.5 and 5mg/kg Systemic Bevacizumab (Avastin®) in Patients With Neovascular Age-Related Macular Degeneration (2007) (0)
- Reply. (2020) (0)
- Can there be smoke without fire? Optical coherence tomography angiography has the answer (2021) (0)
- Visualizing Relative Blood Flow Speeds in Choroidal Neovascularization Using Variable Interscan Time Analysis (VISTA-) Optical Coherence Tomography Angiography (OCTA) (2017) (0)
- Verteporfin Therapy of Juxtafoveal Lesions in Patients with Neovascular AMD (2004) (0)
- Macular thickness measurements from spectral domain and swept-source OCT devices (2019) (0)
- Decreased Central Macular Choriocapillaris Perfusion Correlates with Increased Low Luminance Visual Acuity Deficits. (2023) (0)
- Posterior Pole Measurements Using Spectral Domain Optical Coherence Tomography (2008) (0)
- Verteporfin Therapy with Delayed Light Application for the Treatment of Occult Choroidal Neovascularization (CNV) in Age-Related Macular Degeneration (AMD) (2002) (0)
- Serous PEDs With Associated Subretinal Fluid Unresponsive to Anti-VEGF Therapy (2009) (0)
- Drusen Secondary to Age-Related Macular Degeneration (2017) (0)
- Comment on "Outer Retinal Layer Thickening Predicts the Onset of Exudative Neovascular Age-Related Macular Degeneration". (2021) (0)
- OCT Angiography (OCTA) of Macular Neovascularization (MNV) (2015) (0)
- OCT-based angiography of choroidal neovascularization by removing projection artifacts (2016) (0)
- Intravitreal Bevacizumab (Avastin®) for Macular Edema Secondary to Central Vein Occlusions (2007) (0)
- Reply. (2019) (0)
- Automated 2D and 3D assessment of choroidal thickness and vasculature with swept-source OCT (2019) (0)
- Widefield Choroidal Thickness Maps (2014) (0)
- Retina Choroidal Thickness and Choroidal Vessel Density in Nonexudative Age-Related Macular Degeneration Using Swept-Source Optical Coherence Tomography Imaging (2016) (0)
- SCIENTIFIC EVIDENCE FOR THE ROLE OF VASCULAR ENDOTHELIAL GROWTH FACTOR IN AGE-RELATED MACULAR DEGENERATION * (2005) (0)
- Progression of Geographic Atrophy Predicted by SD-OCT En Face Imaging of the Outer Retina (2013) (0)
- Scientific giant. (2012) (0)
- Spectral Domain Optical Coherence Tomography Characteristics of Vitelliform Macular Detachments in Patients With Basal Laminar Drusen (2007) (0)
- Wide field OCT based microangiography in living human eye (Conference Presentation) (2016) (0)
- Swept Source Optical Coherence Tomography Angiography of Asymptomatic Neovascularization in Intermediate Age-Related Macular Degeneration (2016) (0)
- Swept-Source OCT En Face Imaging of Paravascular Inner Retinal Defects. (2021) (0)
- Correlations Between Changes in OCT Central Retinal Thickness and Visual Acuity in the PrONTO Study (2007) (0)
- Deep learning based GA segmentation in fundus autofluorescence images (2019) (0)
- Targeting VEGF for neovascular age- related macular degeneration and macular edema (2006) (0)
- Anti-VEGF drugs and clinical trials (2007) (0)
- Safety of Repeatedly Intravitreal Injection of Bevacizumab in Rabbit Eyes (2008) (0)
- Spectral Domain Optical Coherence Tomography of Idiopathic Macular Holes and Their Vitreoretinal Relationships (2007) (0)
- Efficacy Of The Systemic Complement Inhibitor Eculizumab In AMD Patients With Drusen: The COMPLETE Study (2012) (0)
- Widefield SS-OCTA for Localization of Retinal Nematode in Diffuse Unilateral Subacute Neuroretinitis. (2021) (0)
- Association between growth of geographic atrophy (GA) and the complement factor I (CFI) Locus (2015) (0)
- Re: Minimizing risks to patients by improving presentation of clinical trial results in geographic atrophy trials (Ophthalmol Retina. 2022;6:337-338). (2022) (0)
- Chapter-122 Neovascular Age-Related Macular Degeneration (2015) (0)
- Type 1 Choroidal Neovascularization Underlying Drusen in Non-Exudative AMD: Artifact versus Reality (2016) (0)
- En-face Imaging of Cysts and Exudates Using Mixtures of Segmentations (2014) (0)
- Avastin (Bevacizumab) Therapy for Perifoveal Telangiectasia (2007) (0)
- Widefield Swept Source OCT Choroidal Thickness Maps and Choroidal Vessel Distribution in Eyes with Dry Age-Related Macular Degeneration (2016) (0)
- Masked Assessment of Widefield En Face Swept Source OCT Imaging Versus Color, Autofluorescence, and Infrared Fundus Imaging for the Diagnosis of Reticular Pseudodrusen (2016) (0)
- Low Luminance Acuity Deficit As A Predictor Of Disease Progression In Eyes With Geographic Atrophy (2012) (0)
- Intravitreous Injection Of Antivascular Endothelial Growth Factor Combined With Injection Of Expansile Gas For Treatment Of Exudative Age-related Macular Degeneration With Posterior Vitreomacular Adhesion (2011) (0)
- Rhegmatogenous Retinal Detachment and Bilateral Optic Disc Coloboma in Organoid Nevus Syndrome (2016) (0)
- Low-Carbohydrate Diet and Coronary Heart Disease in Women (2007) (0)
- Letter to the EditorGeneral correspondenceAuthor reply (2012) (0)
- AM Outer Retinal Tubulation as a Predictor of the Growth Rate of Geographic Atrophy in Age-related Macular Degeneration (2014) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Philip J. Rosenfeld?
Philip J. Rosenfeld is affiliated with the following schools:
